Uveitis  >>  Phase 3
Welcome,         Profile    Billing    Logout  

9 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Uveitis
2018-001931-27: Comparison of therapeutic strategies in childhood ARthritiS Confronto di strategie terapeutiche nell'artrite idiopatica giovanile

Not yet recruiting
3
260
Europe
Solution for infusion in pre-filled syringe, Powder and solution for solution for injection, Reumaflex, Enbrel
IRCCS Istituto Giannina Gaslini, AIFA, Compagnia di San Paolo, Pfizer
Juvenile idiopathic arthritis (JIA) is an umbrella term that encompasses a heterogeneous group of disorders characterised by prolonged synovial inflammation that may cause destructive damage to joint structures. Permanent changes may also develop in extraarticular organs, particularly the eye (as a complication of chronic anterior uveitis), or may result from side effects of medications. L’artrite idiopatica giovanile (AIG) è una malattia cronica caratterizzata da infiammazione persistente alle articolazioni; i segni tipici di infiammazione alle articolazioni sono dolore, gonfiore e limitazione dei movimenti. "Idiopatica" significa che non conosciamo la causa della malattia e "giovanile", in questo caso, significa che l’inizio dei sintomi di solito avviene prima dei 16 anni d’età., Juvenile idiopathic arthritis (JIA) is a chronic disease characterized by persistent inflammation of the joints, pain, swelling and limitation of motion. L’artrite idiopatica giovanile (AIG) è una malattia cronica caratterizzata da infiammazione persistente alle articolazioni, dolore, gonfiore e limitazione dei movimenti., Diseases [C] - Immune System Diseases [C20]
 
 
2019-003638-18: A study to see how safe and how well an investigational medicinal product will work to treat active non-infectious uveitis of the posterior segment of the eye. Uno studio per vedere quanto è sicuro e quanto funziona un medicinale sperimentale per trattare l'uveite non infettiva attiva del segmento posteriore dell'occhio.

Not yet recruiting
3
200
Europe
Opsiria, Predni-POS 1% sospensione oftalmica, Pred Forte 1% collirio sospensione, Prednisolone acetato sospensione ad uso oftalmico USP, 1%, [DE-109], [NA], Solution for injection, Eye drops, suspension, Predni-POS 1% sospensione oftalmica, Pred Forte 1% collirio sospensione, Prednisolone acetato sospensione ad uso oftalmico USP, 1%
SANTEN INCORPORATED, Santen Incorporated
Active, Non-Infectious Uveitis of the Posterior Segment of the Eye. uveite non infettiva attiva del segmento posteriore dell'occhio, Non-Infectious posterior Uveitis. uveite non infettiva posteriore, Body processes [G] - Ocular Physiological Phenomena [G14]
 
 
NCT05070728: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Terminated
3
12
US
Sham Injector, Sham Comparator, FAI Insert, Active Drug
EyePoint Pharmaceuticals, Inc.
Uveitis, Uveitis, Posterior, Uveitis, Intermediate
10/22
04/23
2022-001622-29: A Multicentre Study to Evaluate the Safety and Efficacy of the Eye Implant ILUVIEN® in Children with non-infectious uveitis affecting the posterior segment of the eye Estudio multicéntrico para evaluar la seguridad y la eficacia del implante ocular ILUVIEN® en niños con uveítis no infecciosa que afecta el segmento posterior del ojo

Not yet recruiting
3
25
Europe
ILUVIEN 190 micrograms intravitreal implant in applicator, Intravitreal implant in applicator, ILUVIEN 190 micrograms intravitreal implant in applicator
Alimera Sciences Europe Limited, Alimera Sciences Europe Limited
Non-Infectious Uveitis affecting the posterior segment Uveítis no infecciosa que afecta el segmento posterior del ojo, Non-Infectious Uveitis affecting the posterior segment Uveítis no infecciosa que afecta el segmento posterior del ojo, Diseases [C] - Eye Diseases [C11]
 
 
NCT05042609: A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Completed
3
142
Europe, US
TRS01, FDA approved steroid eye drop (masked)
Tarsier Pharma
Non-infectious Anterior Uveitis, Uveitic Glaucoma
06/23
06/23
NCT04088409 / 2019-000119-10: A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Active, not recruiting
3
40
Europe
Baricitinib, LY3009104, Adalimumab
Eli Lilly and Company
Uveitis
07/23
07/28
CLARITY, NCT06431373: A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Not yet recruiting
3
220
NA
Brepocitinib PO QD, Placebo PO QD
Priovant Therapeutics, Inc.
Uveitis, Posterior, Uveitis, Intermediate, Uveitis
08/26
08/27
NCT05642312: A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

Recruiting
3
225
Europe, Canada, US, RoW
Vamikibart, RO7200220, Sham
Hoffmann-La Roche
Uveitic Macular Edema
06/25
06/25
NCT05642325: Vamikibart in Participants With Uveitic Macular Edema

Recruiting
3
225
Europe, Japan, US, RoW
Vamikibart, RO7200220, Sham
Hoffmann-La Roche
Uveitic Macular Edema
06/25
06/25

Download Options